Trials / Terminated
TerminatedNCT01967199
Drug-eluting Stents vs. Drug-coated Balloon for Preventing Recurrent In-stent Restenosis
Treatment of Drug-Eluting Stent REstenosis Using Drug-Eluting STents vs. Drug-COated Balloon for Preventing REcurrent In-Stent Restenosis
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 175 (actual)
- Sponsor
- Seung-Jung Park · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to establish the safety and effectiveness of paclitaxel eluting balloon (SeQuent Please) compared to coronary stenting with the Everolimus-eluting balloon expandable stent (Xience Prime or Xience Xpedition or Xience Alpine) in the treatment of drug eluting stent restenosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Everolimus-eluting balloon expandable stent | Everolimus-eluting balloon expandable stent (Xience Prime or Xience Xpedition or Xience Alpine) |
| DEVICE | paclitaxel eluting balloon | paclitaxel eluting balloon (SeQuent Please) |
Timeline
- Start date
- 2013-04-18
- Primary completion
- 2017-02-14
- Completion
- 2017-02-14
- First posted
- 2013-10-22
- Last updated
- 2017-02-24
Locations
11 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01967199. Inclusion in this directory is not an endorsement.